Clinical Trial Update: Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating lopinavir/ritonavir monotherapy versus a triple-therapy maintenance regimen in HIV-1 infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED